KMT2D and neoplasm: Among these, drugs that have capability to penetrate the blood-brain barrier (BBB) to reach tumor site were selected and searched in DGIdb to look for interaction with the selected genes (TP53, PIK3CA, PTEN, IL7R and KMT2D).